Acorda Therapeutics, Inc.

ACOR · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$30,360$37,536$45,634$71,369
Short-Term Investments$0$0$0$0
Receivables$17,298$13,866$17,002$20,193
Inventory$16,155$12,752$18,548$28,677
Other Curr. Assets$10,981$17,961$20,973$101,096
Total Curr. Assets$74,794$82,115$102,157$221,335
Property Plant & Equip (Net)$6,300$7,890$11,133$25,744
Goodwill$0$0$0$0
Intangibles$22,987$305,087$335,980$366,981
Long-Term Investments$255$255$6,189$18,609
Tax Assets$9,220$43,031$82,457$86,532
Other NC Assets$4,189-$42,783-$82,446-$86,521
Total NC Assets$42,951$313,480$353,313$411,345
Other Assets$0$0$0$0
Total Assets$117,745$395,595$455,470$632,680
Liabilities
Payables$14,540$10,087$11,815$13,579
Short-Term Debt$187,731$1,545$8,186$76,575
Tax Payable$0$0$0$0
Deferred Revenue$227$384$27,635$0
Other Curr. Liab.$26,442$25,934$6,389$10,355
Total Curr. Liab.$227,773$37,950$54,025$137,252
LT Debt$3,166$171,372$182,756$183,374
Deferred Rev, NC$0$0$37$1,193
Deferred Tax Liab, NC$9,220$44,202$13,930$19,116
Other NC Liab.$35,542$48,449$53,585$53,790
Total NC Liab.$47,928$264,023$250,308$257,473
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$275,701$301,973$304,333$394,725
Equity
Pref Stock$0$0$0$0
Common Stock$1$24$13$9
Retained Earnings-$1,189,127-$936,273-$870,357-$766,403
AOCI$1,425$628-$1,017-$2,803
Other Equity$1,029,745$1,029,243$1,022,498$1,007,152
Total Equity-$157,956$93,622$151,137$237,955
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$117,745$395,595$455,470$632,680
Net Debt$160,537$135,381$145,308$188,580
Acorda Therapeutics, Inc. (ACOR) Financial Statements & Key Stats | AlphaPilot